"Medidata is at the forefront of a critical shift in the life sciences sector," said Anthony Costello, CEO, Medidata. "By harnessing AI-powered solutions and partnering with visionaries, we aren't ...

Those elements could eventually all contribute to Eisai's vision of a "highly transparent and neutral" dementia platform that will aim to relieve the anxieties of patients and their families and ...

By Francis Page, Jr. Click here for updates on this story January 28, 2025 (Houston Style Magazine) — Sisters Network® Inc. (SNI), the nation’s only African American breast cancer survivorship ...

Medical experts came together to address matters concerning the different types of headaches commonly experienced today.

At AcceleDev, Dr. Kang will oversee operations at the company's state-of-the-art facility in Cranbury, New Jersey, guide the expansion of U.S. and China-based operations, and spearhead innovative ...

Opticians, now more often called optometrists, will be able to use the software subsequently developed as a predictive or ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

CRANBURY, NEW JERSEY / ACCESS Newswire / January 28, 2025 / AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process de ...

The project is the second funded and supported by NEURii, a first-of-its-kind global collaboration between the pharmaceutical company Eisai, Gates Ventures ... according to the Lancet Commission, ...

Biogen and Eisai have already filed for approval of their ... condition that can cause problems with balance, movement, vision, speech and swallowing that also features a build-up of toxic tau ...